Back to SYRE
Affinity Asset Advisors, LLC → SYRE
Affinity Asset Advisors, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$113.9M
Q3 2026
Peak value
$113.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $46.9M |
| Q1 2026 | $64.5M |
| Q2 2026 | $113.6M |
| Q3 2026 | $113.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $113.9M | 1.28M | — | — |
| Q2 2026 | $113.6M | 1.28M | — | — |
| Q1 2026 | $64.5M | 1.28M | — | — |
| Q4 2025 | $46.9M | 1.43M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M